These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 33901578)

  • 1. SNHG16 promotes cell proliferation and inhibits cell apoptosis via regulation of the miR-1303-p/STARD9 axis in clear cell renal cell carcinoma.
    Cheng T; Shuang W; Ye D; Zhang W; Yang Z; Fang W; Xu H; Gu M; Xu W; Guan C
    Cell Signal; 2021 Aug; 84():110013. PubMed ID: 33901578
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The ceRNA PVT1 inhibits proliferation of ccRCC cells by sponging miR-328-3p to elevate FAM193B expression.
    Xie G; Zheng X; Zheng Z; Wu R; Yao Z; Huang W; Sun F; Mu X; Wu K; Zheng J
    Aging (Albany NY); 2021 Sep; 13(17):21712-21728. PubMed ID: 34518442
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long non-coding RNA LINC00565 regulates
    Meng B; Wang P; Zhao C; Yin G; Meng X; Li L; Cai S; Yan C
    Chin J Physiol; 2023; 66(6):474-484. PubMed ID: 38149560
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long non-coding RNA SNHG16 promotes lipopolysaccharides-induced acute pneumonia in A549 cells via targeting miR-370-3p/IGF2 axis.
    Zhang J; Mao F; Zhao G; Wang H; Yan X; Zhang Q
    Int Immunopharmacol; 2020 Jan; 78():106065. PubMed ID: 31841752
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LncRNA ADAMTS9-AS2 inhibits cell proliferation and decreases chemoresistance in clear cell renal cell carcinoma via the miR-27a-3p/FOXO1 axis.
    Song EL; Xing L; Wang L; Song WT; Li DB; Wang Y; Gu YW; Liu MM; Ni WJ; Zhang P; Ma X; Zhang X; Yao J; Chen Y; An RH
    Aging (Albany NY); 2019 Aug; 11(15):5705-5725. PubMed ID: 31400752
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LncRNA DNAJC3-AS1 functions as oncogene in renal cell carcinoma via regulation of the miR-27a-3p/PRDM14 axis.
    Na XY; Hu XQ; Zhao Y; Hu CH; Shang XS
    Eur Rev Med Pharmacol Sci; 2021 Feb; 25(3):1291-1301. PubMed ID: 33629299
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LncRNA SNHG16 promotes non-small cell lung cancer development through regulating EphA2 expression by sponging miR-520a-3p.
    Yu L; Chen D; Song J
    Thorac Cancer; 2020 Mar; 11(3):603-611. PubMed ID: 31953899
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SNHG16 Silencing Inhibits Neuroblastoma Progression by Downregulating HOXA7 via Sponging miR-128-3p.
    Bao J; Zhang S; Meng Q; Qin T
    Neurochem Res; 2020 Apr; 45(4):825-836. PubMed ID: 31919621
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Study on the mechanism behind lncRNA MEG3 affecting clear cell renal cell carcinoma by regulating miR-7/RASL11B signaling.
    He H; Dai J; Zhuo R; Zhao J; Wang H; Sun F; Zhu Y; Xu D
    J Cell Physiol; 2018 Dec; 233(12):9503-9515. PubMed ID: 29968912
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LncRNA MAGI2-AS3 inhibites tumor progression by up-regulating STAM via interacting with miR-142-3p in clear cell renal cell carcinoma.
    Yang R; Chen Z; Ao S; Liang L; Chen Z; Duan X; Zeng G; Deng T
    Cell Signal; 2024 Jan; 113():110954. PubMed ID: 38084836
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long non-coding RNA ARAP1-AS1 contributes to cell proliferation and migration in clear cell renal cell carcinoma via the miR-361-3p/placental growth factor axis.
    Zhong L; Zhong X
    Bioengineered; 2021 Dec; 12(1):6629-6642. PubMed ID: 34516333
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LncRNA LINC00667 gets involved in clear cell renal cell carcinoma development and chemoresistance by regulating the miR-143-3p/ZEB1 axis.
    Zhao J; Chen P; Tan C; Cheng X; Zhang W; Shen C; Zhang D
    Aging (Albany NY); 2023 Oct; 15(19):10057-10071. PubMed ID: 37827696
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Depletion of lncRNA MALAT1 inhibited sunitinib resistance through regulating miR-362-3p-mediated G3BP1 in renal cell carcinoma.
    Wang Z; Chang X; Zhu G; Gao X; Chang L
    Cell Cycle; 2020 Aug; 19(16):2054-2062. PubMed ID: 32663095
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long noncoding RNA ZFPM2-AS1 regulates renal cell carcinoma progression via miR-130a-3p/ESCO2.
    Zhang G; Liu SL; Yi WT; Dong YP; Wan YX
    Kaohsiung J Med Sci; 2022 Jun; 38(6):530-541. PubMed ID: 35258173
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The long non-coding RNA NNT-AS1 promotes clear cell renal cell carcinoma progression via regulation of the miR-137/ Y-box binding protein 1 axis.
    Zhou Y; Zhang Z; Wo M; Xu W
    Bioengineered; 2021 Dec; 12(1):8994-9005. PubMed ID: 34643163
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long noncoding RNA lung cancer associated transcript 1 promotes proliferation and invasion of clear cell renal cell carcinoma cells by negatively regulating miR-495-3p.
    Wang LN; Zhu XQ; Song XS; Xu Y
    J Cell Biochem; 2018 Sep; 119(9):7599-7609. PubMed ID: 29932248
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long non-coding RNA ZFAS1 promotes proliferation and metastasis of clear cell renal cell carcinoma via targeting miR-10a/SKA1 pathway.
    Dong D; Mu Z; Wei N; Sun M; Wang W; Xin N; Shao Y; Zhao C
    Biomed Pharmacother; 2019 Mar; 111():917-925. PubMed ID: 30841471
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LINC02532 Contributes to Radiosensitivity in Clear Cell Renal Cell Carcinoma through the miR-654-5p/YY1 Axis.
    Zhou X; Zeng B; Li Y; Wang H; Zhang X
    Molecules; 2021 Nov; 26(22):. PubMed ID: 34834139
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Silencing lncRNA SLC16A1-AS1 Induced Ferroptosis in Renal Cell Carcinoma Through miR-143-3p/SLC7A11 Signaling.
    Li YZ; Zhu HC; Du Y; Zhao HC; Wang L
    Technol Cancer Res Treat; 2022; 21():15330338221077803. PubMed ID: 35167383
    [No Abstract]   [Full Text] [Related]  

  • 20. Blocking lncRNA MIR155HG/miR-155-5p/-3p inhibits proliferation, invasion and migration of clear cell renal cell carcinoma.
    Tao M; Zhou Y; Jin Y; Pu J
    Pathol Res Pract; 2020 Feb; 216(2):152803. PubMed ID: 31889587
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.